Litigation Details for Purdue Pharma L.P. v. Accord Healthcare Inc. (D. Del. 2020)

Purdue Pharma L.P. v. Accord Healthcare Inc. (D. Del. 2020)

Docket		Date Filed	2020-10-08
Court	District Court, D. Delaware	Date Terminated	2023-04-26
Cause	35:1 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	None	Referred To
Patents	10,407,434; 6,488,963; 8,808,741; 8,894,987; 8,894,988; 9,073,933; 9,492,389; 9,492,391; 9,492,392; 9,492,393; 9,522,919; 9,763,933; 9,775,808
Link to Docket	External link to docket

Details for Purdue Pharma L.P. v. Accord Healthcare Inc. (D. Del. 2020)

Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2023-04-11	118	Opinion	OxyContin. (DTX-008). 7. United States Patent No. 6,488,963 to McGinity ("McGinity") is prior…of the Mannion '933 patent, claim 3 of the '808 patent, claim 6 of the '886 patent, claims 3 and 11 of…808 patent, and claim 6 of the ' 886 patent. The second group consists of U.S. Patent Nos… ' 933 patent, claim 3 of the ' 808 patent, and claim 6 of the '886 patent. Claim 3 of…Mannion '933 patent at 159:21-22; ' 808 patent at 159:62-63 ; ' 886 patent at 172:30). All	External link to document
2023-04-26	126	Judgment	quot;the ' 933 patent"), and 9,522,919 ("the ' 919 patent") (D .I. 1); … (5) that claim 21 of U.S. Patent No. 9,522,919 is declared to be invalid on the ground… ' 933 patent, the ' 808 patent, the ' 886 patent, the ' 933 patent, and the '…quot;) infringed U.S . Patent Nos. 9,763 ,933 ("the Mannion ' 933 patent"), 9,775 ,808 (… ("the ' 808 patent"), 9,763 ,886 ("the ' 886 patent"), 9,073 ,933 ("	External link to document
2023-04-26	127	Patent/Trademark Report to Commissioner of Patents	B2; 9,763,886 B2; 9,073,933 B2; 9,522,919 B2; 10,407,434 B2. (Attachments: # 1 Final Judgment)(nms) (Entered… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,763,933 B2; …2020 26 April 2023 1:20-cv-01362 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2021-03-11	14	Counterclaim AND Answer to Complaint	the ‘886 patent”); 9,073,933 (“the ’933 patent”); 9,522,919 (“the ’919 patent”); and 10,407,434 (“the ’…RELIEF (PATENT INFRINGEMENT OF U.S. PATENT NO. 10,407,434) 74. Purdue and…, 2019, the USPTO issued U.S. Patent No. 10,407,434 (“the ‘434 patent), entitled “PROCESS FOR PREPARING…Mannion ‘933 patent, the ‘808 patent, the ‘886 patent, the ‘933 patent, the ‘919 patent, and the ‘434…United States Patent Nos. 9,763,933 (“the Mannion ’933 patent”); 9,775,808 (“the ’808 patent”); 9,763,886	External link to document
2020-10-08	4	Patent/Trademark Report to Commissioner of Patents	; 9,775,808 B2 ; 9,763,886 B2 ; 9,073,933 B2 ; 9,522,919 B2. (kmd) (Entered: 10/08/2020) 8 October… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,763,933 B2 ;…2020 26 April 2023 1:20-cv-01362 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document